1. Home
  2. OPRA vs NTLA Comparison

OPRA vs NTLA Comparison

Compare OPRA & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRA
  • NTLA
  • Stock Information
  • Founded
  • OPRA 1996
  • NTLA 2014
  • Country
  • OPRA Norway
  • NTLA United States
  • Employees
  • OPRA N/A
  • NTLA N/A
  • Industry
  • OPRA Computer Software: Prepackaged Software
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • OPRA Technology
  • NTLA Health Care
  • Exchange
  • OPRA Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • OPRA 1.2B
  • NTLA 1.2B
  • IPO Year
  • OPRA 2018
  • NTLA 2016
  • Fundamental
  • Price
  • OPRA $13.47
  • NTLA $8.61
  • Analyst Decision
  • OPRA Strong Buy
  • NTLA Buy
  • Analyst Count
  • OPRA 3
  • NTLA 22
  • Target Price
  • OPRA $23.83
  • NTLA $19.83
  • AVG Volume (30 Days)
  • OPRA 987.2K
  • NTLA 12.0M
  • Earning Date
  • OPRA 10-29-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • OPRA 5.94%
  • NTLA N/A
  • EPS Growth
  • OPRA N/A
  • NTLA N/A
  • EPS
  • OPRA 0.90
  • NTLA N/A
  • Revenue
  • OPRA $583,449,000.00
  • NTLA $57,528,000.00
  • Revenue This Year
  • OPRA $27.64
  • NTLA $8.51
  • Revenue Next Year
  • OPRA $15.07
  • NTLA N/A
  • P/E Ratio
  • OPRA $14.98
  • NTLA N/A
  • Revenue Growth
  • OPRA 30.29
  • NTLA 33.52
  • 52 Week Low
  • OPRA $12.83
  • NTLA $5.90
  • 52 Week High
  • OPRA $22.50
  • NTLA $28.25
  • Technical
  • Relative Strength Index (RSI)
  • OPRA 32.35
  • NTLA 30.25
  • Support Level
  • OPRA $13.57
  • NTLA $8.96
  • Resistance Level
  • OPRA $14.31
  • NTLA $10.33
  • Average True Range (ATR)
  • OPRA 0.65
  • NTLA 1.12
  • MACD
  • OPRA -0.02
  • NTLA -0.74
  • Stochastic Oscillator
  • OPRA 11.05
  • NTLA 3.90

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: